Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fate Therapeutics
AstraZeneca
Merck Sharp & Dohme LLC
Deciphera Pharmaceuticals, LLC
Sun Yat-sen University
QuantumLeap Healthcare Collaborative
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Oncology Institute of Southern Switzerland
Merrimack Pharmaceuticals
National Cancer Institute (NCI)